These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3157510)

  • 101. Separation and analysis of mononuclear cells infiltrating the thyroid of patients with Graves' disease.
    Aozasa M; Amino N; Iwatani Y; Tamaki H; Tachi J; Fujiyasu S; Nasu M; Matsuzuka F; Kuma K; Miyai K
    Clin Immunol Immunopathol; 1987 Jun; 43(3):343-53. PubMed ID: 3581516
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Maturation of thyroidal dendritic cells in Graves' disease.
    Quadbeck B; Eckstein AK; Tews S; Walz M; Hoermann R; Mann K; Gieseler R
    Scand J Immunol; 2002 Jun; 55(6):612-20. PubMed ID: 12028565
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Normal suppressive T cell function of Epstein-Barr virus induced B cell activation in type 1 (insulin dependent) diabetes mellitus.
    Kahan A; LeFloch JP; Charreire J
    Autoimmunity; 1990; 5(4):257-64. PubMed ID: 1966582
    [TBL] [Abstract][Full Text] [Related]  

  • 104. mRNA-Seq reveals novel molecular mechanisms and a robust fingerprint in Graves' disease.
    Yin X; Sachidanandam R; Morshed S; Latif R; Shi R; Davies TF
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2076-83. PubMed ID: 24971664
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Is remission of Graves' disease regulated by anti-idiotypic antibodies?
    Paschke R; Teuber J; Schwedes U; Usadel KH
    Acta Endocrinol Suppl (Copenh); 1987; 281():99-103. PubMed ID: 3497516
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Expression of integrins of the beta1 family in thyroid cells from patients with Graves' disease in vivo and in vitro.
    Vitale M; De Riu S; Fenzi GF; Casamassima A; Salzano S; Müeller F; Marzano LA; Rossi G
    Biochimie; 1999 May; 81(5):477-84. PubMed ID: 10403178
    [TBL] [Abstract][Full Text] [Related]  

  • 107. T lymphocytes in Graves' disease.
    Volpé R
    Clin Endocrinol (Oxf); 1988 Aug; 29(2):195-6. PubMed ID: 2977744
    [No Abstract]   [Full Text] [Related]  

  • 108. Autoimmunity and thyroid growth: methods, concepts and misconceptions.
    Dumont JE; Roger P; Ludgate M
    Acta Endocrinol Suppl (Copenh); 1987; 281():299-301. PubMed ID: 3475911
    [No Abstract]   [Full Text] [Related]  

  • 109. Mechanism and significance of abnormal blood level of beta 2-microglobulin in patients with Graves' disease.
    Han XL; Yie WX
    J Tongji Med Univ; 1988; 8(1):35-40. PubMed ID: 2974088
    [No Abstract]   [Full Text] [Related]  

  • 110. Lymphocyte subpopulations in Graves' disease.
    Volpé R
    Clin Endocrinol (Oxf); 1987 Dec; 27(6):735-6. PubMed ID: 2970901
    [No Abstract]   [Full Text] [Related]  

  • 111. Dexamethasone Suppression Tests in Graves' Disease [Abridged].
    Gilliland IC; Ghose MB
    Proc R Soc Med; 1962 Feb; 55(2):130-1. PubMed ID: 19994146
    [No Abstract]   [Full Text] [Related]  

  • 112. Thyroid function: Lithium improves Graves therapy.
    Mitchell F
    Nat Rev Endocrinol; 2012 Apr; 8(6):319. PubMed ID: 22508096
    [No Abstract]   [Full Text] [Related]  

  • 113. Growth Centers of the benign Blastomata with especial Reference to Thyroid and prostatic Adenomata.
    Simpson BT
    J Med Res; 1913 Jan; 27(3):269-290.7. PubMed ID: 19972086
    [No Abstract]   [Full Text] [Related]  

  • 114. ADENOMATA OF THE THYROID GLAND.
    Schneider EH
    Cal State J Med; 1924 Jan; 22(1):22-4. PubMed ID: 18739185
    [No Abstract]   [Full Text] [Related]  

  • 115. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms.
    Huber A; Menconi F; Corathers S; Jacobson EM; Tomer Y
    Endocr Rev; 2008 Oct; 29(6):697-725. PubMed ID: 18776148
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic Goiter and in Graves' disease.
    Grubeck-Loebenstein B; Londei M; Greenall C; Pirich K; Kassal H; Waldhäusl W; Feldmann M
    J Clin Invest; 1988 May; 81(5):1608-14. PubMed ID: 3130398
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Functional immunoregulatory T-cell abnormalities in cystic fibrosis patients.
    Lahat N; Rivlin J; Iancu TC
    J Clin Immunol; 1989 Jul; 9(4):287-95. PubMed ID: 2527866
    [TBL] [Abstract][Full Text] [Related]  

  • 118. T-cell sensitization to autologous thyroid cells and normal non-specific suppressor T-cell function in Graves' disease.
    Davies TF; Bermas B; Platzer M; Roman SH
    Clin Endocrinol (Oxf); 1985 Feb; 22(2):155-67. PubMed ID: 3157510
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Specific suppressor T cell function in a patient with Graves' disease and her healthy identical twin.
    Balázs C; Stenszky V; Kozma L; Farid NR
    Clin Endocrinol (Oxf); 1984 Jun; 20(6):683-93. PubMed ID: 6235984
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease.
    Ishikawa N; Eguchi K; Otsubo T; Ueki Y; Fukuda T; Tezuka H; Matsunaga M; Kawabe Y; Shimomura C; Izumi M
    J Clin Endocrinol Metab; 1987 Jul; 65(1):17-23. PubMed ID: 2953751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.